An interventional study of Communal drumming recordings in Mental Health Issue and COVID-19, sponsored by Yale University. Completed at 2 sites in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.
Sponsored by Yale University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in COVID-19 by Yale University — 1 open to participants now, 1 under way, none of them phase 3. COVID-19 · Yale University.
Among the 20 studies in COVID-19 by Yale University, this one is the 12th largest by enrollment of the 17 interventional ones that give a count, is one of 6 that started in 2024, is one of 11 with no phase, and was the 16th registered.
7,996 studies on the registry are indexed under COVID-19; 469 are open to participants now.
Browse COVID-19 studies →1 of the 20 studies in COVID-19 by Yale University is open now, in 1 country. Recruiting first, the newest first:
Yale University · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 356 COVID-19 studies recruiting now, 205 (58%) set no upper age limit and 84 (24%) stop at 75 or younger; 90 take children under 18; 135 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 3 1
First in 2020; this study’s year is marked. 6 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 28 is below the median of 102 across 4,369 interventional studies indexed under COVID-19.
Median enrollment 63 across the 17 interventional studies, 1,320 across the 3 observational. Of the 17 that completed or were terminated, 5 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
Yale University is the lead sponsor of 1,773 studies on the registry; 298 are open to participants now.
Of its 221 completed or terminated interventional studies of FDA-regulated products, 129 (58%) have results posted.
1 of the studies in COVID-19 by Yale University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05796505Yale UniversityAddressing Vaccine Acceptance in Carceral Settings Through Community Engagement | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 20 studies in COVID-19 by Yale University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Mental health vulnerability due to stress is increased in People of African Descent (PADs) in America due to disproportionate effects of racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multiple negative dimensions of stress. However, the majority of these studies do not have an adequate representation of PADs or other marginalized groups and are not designed to be culturally relevant or community based. Music has been shown to alleviate multiple symptoms of stress and has been shown to be a preferred and effective support for meditation and mindfulness. However, its role in stress management in PADs engaged in meditation or mindfulness is seldom studied. This study aims to evaluate the effects of a virtual, community-based music mindfulness program on stress management in PAD community members with anxiety and depression during COVID19.
2c.a. Drum Circle Synchrony Study: This study will investigate the role that synchrony plays in subjective feelings of connection.
The investigators also propose a study to investigate the effects of communal drumming in reducing anxiety and increasing connectedness within drum circle community. Investigators hypothesize that these intervention will lead to reductions in scores on stress scales and will provide preliminary data for studies evaluating these types of community programs as an adjunct to the standard of care.
Musicians and non-musicians will listen to segments (\~30 sec duration) of recordings taken from the music made during a previous arm of drum circle and answer a survey. Segments will be categorized as highly synchronized or not synchronized.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Musicians will listen to segments (\~30 sec duration) of recordings taken from the music made during the previous drum circle and answer a survey asking how connected they felt while listening.Segments will be categorized as highly synchronized or not synchronized.
Behavioral: Communal drumming recordings
Non-musicians will listen to segments (\~30 sec duration) of recordings taken from the music made during the previous drum circle and answer a survey asking how connected they felt while listening.Segments will be categorized as highly synchronized or not synchronized..
Behavioral: Communal drumming recordings
Segments (\~30 sec duration) of recordings taken from the music made during the previous drum circle. Segments will be categorized as highly synchronized
Mean score connectedness rating
Mean connectedness rating survey assessed using a Likert scale total range of 1 (no connection) to 7 (maximum connection) for synchronous and asynchronous audio samples
Time frame: measured during listening session (30minutes)
Mean score subjective rating of synchrony
Subjective ratings of synchrony will be assessed using a Likert scale with total score range from 1-5, with higher scores indicating more synchrony, for synchronous and asynchronous audio samples.
Time frame: measured during listening session (30minutes)
Plan to share: Yes — De-identified, aggregate data will be shared through pre-prints, publications, and community town hall meetings.
No publications or documents are linked to this record.
Ran from Aug 2024 to primary completion in Dec 2025, 16 months.
Of 1,337 non-industry interventional studies with no phase under COVID-19, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 20. This study's 16 months is above that.
Counting every sponsor, half of 1,475 studies reached it within 9 months; a quarter within 3 and three quarters within 19.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 19, 2026: primary completion Mar 2026 → Dec 2025 and completion Mar 2026 → Dec 2025.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.